tradingkey.logo

Embecta Corp

EMBC
12.080USD
+0.160+1.34%
Close 12/24, 13:00ETQuotes delayed by 15 min
706.63MMarket Cap
7.38P/E TTM

Embecta Corp

12.080
+0.160+1.34%

More Details of Embecta Corp Company

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp Info

Ticker SymbolEMBC
Company nameEmbecta Corp
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)
Number of employees1850
Security typeOrdinary Share
Fiscal year-endMar 21
Address300 Kimball Drive
CityPARSIPPANY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07054
Phone18624010000
Websitehttps://www.embecta.com/
Ticker SymbolEMBC
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)

Company Executives of Embecta Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Pravesh Khandelwal
Mr. Pravesh Khandelwal
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%
By RegionUSD
Name
Revenue
Proportion
United States
160.20M
54.21%
International
135.30M
45.79%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
Other
58.93%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
Other
58.93%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.94%
Investment Advisor/Hedge Fund
31.49%
Hedge Fund
10.58%
Research Firm
5.48%
Pension Fund
2.25%
Individual Investor
1.46%
Bank and Trust
0.54%
Family Office
0.40%
Sovereign Wealth Fund
0.19%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
771
58.75M
107.09%
-8.51K
2025Q3
810
58.76M
110.40%
-1.03M
2025Q2
820
59.48M
109.25%
+307.16K
2025Q1
855
59.15M
106.14%
-2.75M
2024Q4
884
57.08M
105.66%
+385.73K
2024Q3
903
56.12M
114.14%
-1.32M
2024Q2
966
57.37M
112.89%
+262.03K
2024Q1
996
57.10M
113.18%
-8.07M
2023Q4
1007
56.71M
107.91%
+769.57K
2023Q3
972
57.63M
107.02%
+1.71M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.03M
13.73%
-278.98K
-3.36%
Jun 30, 2025
The Vanguard Group, Inc.
5.40M
9.24%
-1.27M
-19.01%
Jun 30, 2025
American Century Investment Management, Inc.
5.20M
8.88%
+1.38M
+36.25%
Jun 30, 2025
River Road Asset Management, LLC
3.24M
5.54%
+12.35K
+0.38%
Jun 30, 2025
Deerfield Management Company, L.P.
2.75M
4.7%
+29.18K
+1.07%
Jun 30, 2025
State Street Investment Management (US)
2.40M
4.1%
+15.14K
+0.64%
Jun 30, 2025
Yacktman Asset Management LP
2.37M
4.06%
+16.07K
+0.68%
Jun 30, 2025
Jefferies LLC
1.34M
2.3%
+769.71K
+134.33%
Jun 30, 2025
William Blair Investment Management, LLC
1.99M
3.41%
+14.23K
+0.72%
Jun 30, 2025
Millennium Management LLC
1.82M
3.12%
+937.99K
+105.75%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ETC 6 Meridian Small Cap Equity ETF
1.09%
State Street SPDR S&P Health Care Equipment ETF
0.85%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
Invesco S&P Spin-Off ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.49%
Invesco S&P SmallCap Health Care ETF
0.48%
Global X Aging Population ETF
0.31%
Royce Quant Small-Cap Quality Value ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.19%
View more
ETC 6 Meridian Small Cap Equity ETF
Proportion1.09%
State Street SPDR S&P Health Care Equipment ETF
Proportion0.85%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.65%
Invesco S&P Spin-Off ETF
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.49%
Invesco S&P SmallCap Health Care ETF
Proportion0.48%
Global X Aging Population ETF
Proportion0.31%
Royce Quant Small-Cap Quality Value ETF
Proportion0.29%
Inspire Small/Mid Cap ESG ETF
Proportion0.19%

Dividend

A total of 112.50M USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Aug 08, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
May 09, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2025 going ex on May 28, 2025
May 28, 2025
Jun 13, 2025
May 28, 2025
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
Aug 08, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Sep 13, 2023
Aug 24, 2023
May 12, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2023 going ex on May 25, 2023
May 29, 2023
Jun 13, 2023
May 25, 2023
View more

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Embecta Corp?

The top five shareholders of Embecta Corp are:
BlackRock Institutional Trust Company, N.A. holds 8.03M shares, accounting for 13.73% of the total shares.
The Vanguard Group, Inc. holds 5.40M shares, accounting for 9.24% of the total shares.
American Century Investment Management, Inc. holds 5.20M shares, accounting for 8.88% of the total shares.
River Road Asset Management, LLC holds 3.24M shares, accounting for 5.54% of the total shares.
Deerfield Management Company, L.P. holds 2.75M shares, accounting for 4.70% of the total shares.

What are the top three shareholder types of Embecta Corp?

The top three shareholder types of Embecta Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.

How many institutions hold shares of Embecta Corp (EMBC)?

As of 2025Q4, 771 institutions hold shares of Embecta Corp, with a combined market value of approximately 58.75M, accounting for 107.09% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -3.30%.

What is the biggest source of revenue for Embecta Corp?

In FY2025Q3, the Pen Needles business generated the highest revenue for Embecta Corp, amounting to 216.90M and accounting for 73.40% of total revenue.
KeyAI